Sundrug Co Ltd
TSE:9989
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (1.9), the stock would be worth ¥4 524.39 (20% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.6 | ¥3 781 |
0%
|
| 3-Year Average | 1.9 | ¥4 524.39 |
+20%
|
| 5-Year Average | 1.9 | ¥4 460.49 |
+18%
|
| Industry Average | 1.6 | ¥3 816.55 |
+1%
|
| Country Average | 1.4 | ¥3 368.12 |
-11%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Sundrug Co Ltd
TSE:9989
|
442.3B JPY | 1.6 | 14.2 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
62.7B ZAR | 9.1 | 19.4 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
31.3B ZAR | 5.6 | 25.3 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | 1.4 | -1.6 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
39.3B BRL | 5.4 | 30.3 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
958.3B JPY | 1.1 | 22.5 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
929.2B JPY | 1.8 | 16.6 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 6.1 | 20.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
29.2B CNY | 2.5 | 16.9 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 2.5 | 34.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
578.9B JPY | 2 | 12.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.1 |
| Median | 1.4 |
| 70th Percentile | 2.1 |
| Max | 31 732 017.6 |
Other Multiples
Sundrug Co Ltd
Glance View
In the bustling landscape of Japanese retail, Sundrug Co., Ltd. emerges as a leader with its distinct approach to health and beauty. Founded in 1965, the company has grown from a single store to a robust network of over a thousand outlets, strategically located across Japan. This extensive expansion is driven by Sundrug’s commitment to offering an expansive range of products, from pharmaceuticals and cosmetics to everyday household goods. By positioning themselves as a one-stop shop for daily essentials and health-related products, they have captured a significant share of the market. Their success is underpinned by thoughtful site selection, prioritizing convenience and accessibility, which attracts a steady stream of customers. Sundrug's business model thrives on a combination of competitive pricing and exceptional customer service, which have become their hallmark. They operate on a high-volume, low-margin strategy, allowing them to keep their prices attractive and foster customer loyalty. In addition to physical stores, Sundrug has embraced e-commerce, recognizing the shift in consumer behavior towards online shopping. Through an omnichannel approach, the company has integrated its physical and digital platforms, enhancing the customer experience by offering the flexibility of in-store pickups and home deliveries. This strategic blend of traditional and digital retail, coupled with efficient supply chain management, is how Sundrug effectively generates its revenue and sustains its market position.